« Return to News | Awards & Advancement

ERT awarded over $10 Million in ePRO business

Thursday, April 14, 2011 11:59 AM

ERT, a provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, was awarded three new contracts with pharmaceutical companies, totalling over $10 million for its electronic patient reported outcomes (ePRO) business.

The first ePRO award is an agreement with a specialty division of a pharmaceutical company that has selected ERT to manage a suite of studies using ERT’s proprietary VIAPhone platform over the next three years.  The contract will be worth in excess of $7 million. The second award is part of a $3.0 million contract for which ERT will provide its VIAPen solution for a pivotal phase III program. The third award has been secured with a pharmaceutical company that will be using ERT’s VIAPhone Pain Diary for use in a phase III clinical trial, alongside its VIAPen solution for site assessments.

John Blakeley, chief commercial officer at ERT, comments: “The broad scope of our solutions and expertise ensures that we are able to offer clients unbiased, ‘true partnership’ advice that allows for an accurate and cost-effective trial. Sponsors are increasingly choosing ERT for our industry knowledge and expertise as well as secure and reliable service.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.